Cargando…
Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak
PURPOSE: To report a case of ocular involving monkeypox infection in the United States during the 2022 outbreak, and to review the literature regarding its clinical manifestations and management known to date. OBSERVATIONS: A 36-year-old man with well controlled HIV presented to the emergency depart...
Autores principales: | Perzia, Brittany, Theotoka, Despoina, Li, Katie, Moss, Emily, Matesva, Mitchelle, Gill, Mohsain, Kibe, Mercy, Chow, Jessica, Green, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744718/ https://www.ncbi.nlm.nih.gov/pubmed/36573234 http://dx.doi.org/10.1016/j.ajoc.2022.101779 |
Ejemplares similares
-
Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022) -
Monkeypox treatment: Is tecovirimat the answer?
por: Niaz, Faizan, et al.
Publicado: (2022) -
Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat
por: Hernandez, Loren E, et al.
Publicado: (2022) -
In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat
por: Nunes, Desiree dos Santos, et al.
Publicado: (2023) -
Tecovirimat use among patients with monkeypox (mpox) in Alameda County, California, June–October 2022
por: Ouyang, Megan, et al.
Publicado: (2023)